These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25921167)

  • 61. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.
    Pandith AA; Khan NP; Rashid N; Azad N; Zaroo I; Hafiz A; Siddiqi MA
    Tumour Biol; 2012 Aug; 33(4):927-33. PubMed ID: 22249977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.
    Chua HW; Ng D; Choo S; Lum SS; Li H; Soh LY; Sabapathy K; Seow A
    BMC Cancer; 2010 Mar; 10():88. PubMed ID: 20219101
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.
    Shaffi SM; Shah MA; Bhat IA; Koul P; Ahmad SN; Siddiqi MA
    Asian Pac J Cancer Prev; 2009; 10(4):651-6. PubMed ID: 19827888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
    Hao W; Xu X; Shi H; Zhang C; Chen X
    Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Distribution of poly(ADP-ribose) polymerase pseudogene polymorphism and association with susceptibility to lung cancer in Chinese people].
    Tang L; Ren Z; Zhuang Z; Liu X; Su Z; Huang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):124-6. PubMed ID: 11941587
    [TBL] [Abstract][Full Text] [Related]  

  • 68. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.
    Dai S; Mao C; Jiang L; Wang G; Cheng H
    Hum Genet; 2009 Jun; 125(5-6):633-8. PubMed ID: 19357867
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Association of polymorphic markers Arg72Pro of TP53 and T309g of MDM2 genes with non small cell lung cancer in Russians of Moscow region].
    Loginov VI; Atkarskaia MV; Burdennyĭ AM; Zavarykina TM; Kazubskaia TP; Nosikov VV; Braga ÉA; Zhizhina GP
    Mol Biol (Mosk); 2014; 48(1):62-8. PubMed ID: 25842826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic polymorphisms in DNA repair genes and risk of lung cancer.
    Butkiewicz D; Rusin M; Enewold L; Shields PG; Chorazy M; Harris CC
    Carcinogenesis; 2001 Apr; 22(4):593-7. PubMed ID: 11285194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CYP19A1 gene polymorphisms and risk of lung cancer.
    Zhang J; Yin Y; Niu XM; Liu Y; Garfield D; Chen SF; Wang R; Wang L; Chen HQ
    J Int Med Res; 2013 Jun; 41(3):735-42. PubMed ID: 23669293
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients.
    Zemleduch T; Lianeri M; Rydzanicz M; Gajecka M; Szyfter K; Jagodziński PP
    Oral Oncol; 2009 Aug; 45(8):683-6. PubMed ID: 19091625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
    Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
    Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
    Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
    Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
    Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
    Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
    Cui Y; Morgenstern H; Greenland S; Tashkin DP; Mao J; Cao W; Cozen W; Mack TM; Zhang ZF
    Int J Cancer; 2006 Feb; 118(3):714-20. PubMed ID: 16094634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.